<DOC>
	<DOCNO>NCT00002370</DOCNO>
	<brief_summary>To demonstrate dosage regimen intravenous itraconazole produce plasma concentration range comparable obtain currently use oral dosage itraconazole oral solution ; obtain preliminary safety data patient advance HIV disease .</brief_summary>
	<brief_title>Study Itraconazole Patients With Advanced HIV Infection</brief_title>
	<detailed_description>Patients receive intravenous itraconazole solution twice daily 2 day daily five additional day . Patients randomized receive twice-daily once-daily itraconazole oral solution additional 28 day .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<mesh_term>Itraconazole</mesh_term>
	<mesh_term>Hydroxyitraconazole</mesh_term>
	<criteria>Inclusion Criteria Concurrent Medication : Allowed : Antiretroviral therapy provide patient already stable , unchanged regimen 8 week prior study entry . Patients must : Documented HIV infection . CD4 lymphocyte count &lt; 300 cells/mm3 . No clinically significant abnormality , elicit history physical examination . No clinically significant abnormality blood count , biochemical profile , urinalysis within 2 week study entry . Negative urine screening . No clinically significant abnormality electrocardiogram . Prior Medication : Allowed : Antiretroviral therapy provide patient stable , unchanged regimen 8 week prior study entry . Exclusion Criteria Coexisting Condition : Patients follow symptoms condition exclude : Acute opportunistic infection significant concurrent illness would preclude participation require 36 day . Unable swallow oral solution . Obesity great 25 % ideal body weight . Concurrent Medication : Excluded : Rifampin . Rifabutin . Phenobarbital . Phenytoin . Carbamazepine . Digoxin . Warfarin . Midazolam . Triazolam . Terfenadine . Astemizole . Cisapride . H2 blocker . Omeprazole . Continual antacid . Didanosine . Any medication know affect absorption , metabolism excretion imidazole azole compound . Patients follow prior symptom condition exclude : Previous hypersensitivity azole antifungal . History surgical procedure may interfere absorption itraconazole . History significant blood loss previous 30 day . Prior Medication : Excluded : Excluded within 15 day prior study entry : Rifampin . Rifabutin . Phenobarbital . Phenytoin . Carbamazepine . Digoxin . Warfarin . Midazolam . Triazolam . Excluded within 8 week prior study entry : Change antiretroviral therapy . Risk Behavior : Excluded : Patients chew tobacco regularly smoke 10 cigarette per day .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 1997</verification_date>
	<keyword>Itraconazole</keyword>
	<keyword>Administration , Oral</keyword>
	<keyword>Antifungal Agents</keyword>
	<keyword>Acquired Immunodeficiency Syndrome</keyword>
	<keyword>Drug Administration Schedule</keyword>
</DOC>